Skip to the page

Data / Medical devices / South Korea / Nextbiomedical Co., Ltd

Nextbiomedical Co., Ltd: FDA-registered device maker in Incheon, South Korea, 2 510(k) clearances

Nextbiomedical Co., Ltd is registered with the FDA (registration 3020614064) in Incheon, South Korea. It lists 1 device type. The FDA files 2 510(k) clearances under its listings, the newest dated November 27, 2024. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3020614064
Address
6, Venture-ro 100beon-gil, Yeonsu-gu, Incheon, South Korea, 22013
Owner or operator
NEXTBIOMEDICAL CO., LTD (10084721)
Roles
Complaint file establishment, Manufacturer
First device listed
September 19, 2022
Registered through
2027
Brand names listed
Nexpowder

Devices it lists

DeviceProduct codeClassRoleSource
Hemostatic Device For Endoscopic Gastrointestinal UseQAU2Complaint file establishment, Manufactureraccessdata.fda.gov

510(k) clearances

The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.

Decided510(k) numberDeviceProduct codeDecisionApplicantSource
November 27, 2024K240994NexpowderQAUSubstantially EquivalentNextbiomedical Co., Ltd.accessdata.fda.gov
September 16, 2022K202929NexpowderQAUSubstantially EquivalentNextbiomedical Co., Ltd.accessdata.fda.gov

Compare with other makers

Updated November 27, 2024. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.